Status:
COMPLETED
Increasing Adherence to Pulmonary Rehabilitation After COPD Related Hospitalizations (Study 2)
Lead Sponsor:
Mayo Clinic
Collaborating Sponsors:
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
COPD Exacerbation
Eligibility:
All Genders
40+ years
Phase:
NA
Brief Summary
This study is being done to test the comparative effectiveness of participating in a Pulmonary Rehabilitation Program at home using new technology and health coaching following dismissal from the hosp...
Detailed Description
Despite proven benefits, the proportion of people with COPD who receive Pulmonary Rehabilitation (PR) is very small. The current model of a center-based PR program fails to address the needs of many p...
Eligibility Criteria
Inclusion
- COPD related hospitalization and eligible for PR
- Age 40+
- Confidence (score \> 5 in a self-efficacy question (1-10 scale): how confident you feel to use this system on a daily basis)
Exclusion
- \- Inability to walk (orthopedic-neurologic problems or confined to bed)
Key Trial Info
Start Date :
November 30 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 19 2024
Estimated Enrollment :
296 Patients enrolled
Trial Details
Trial ID
NCT04521608
Start Date
November 30 2020
End Date
September 19 2024
Last Update
November 21 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Health Partners Institute
Bloomington, Minnesota, United States, 55425
2
Mayo Clinic in Rochester
Rochester, Minnesota, United States, 55905